1[1]Freedman DS,Williamson DF ,Gunter EN ,et al .Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiclogic follow-up study. AMJ Epidemiol [J]. 1995, 141(7): 637-644.
2[2]Edwards RM, Trizna W, stack EJ. Interation of nonpeptide angiotension Ⅱ receptor antagonists with the urate transporter in rat renal brush-border membranes [J]. J Pharmacol Exp Ther,1996, 276 (1): 125-129.
3[3]Urata H, Boehm K, Philip A et al. Human Chymase: Cellular localization and regional distribution of an angiotensin Ⅱ forming chymase in the heart [J]. J Clin Invest, 1993, 91 (4): 1269-1287.
5Levya F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J, 1997,18(5): 858 - 865.
6Ferris TF, Gorden P. Effect Of Angiotension And Norepinephrine upon Urate Clearance In Man. Am J Med, 1968, 44(3):359-365.
7Levya F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1998, 19(12):1746 - 1747.
8Olexa P, Olexova M, Gonsorcik J, et al. Uric acid-a marker for systemic inflammatory response in patients with congestive heart failure?. Wien Klin Wochenschr 2002, 114(5 -6) : 211 -215.
9陈文彬 主编.诊断学:第5版[M].北京:人民卫生出版社,2002.382～383.
10Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
